Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease: One Step Closer to the Clinical Scenario
- PMID: 37197844
- DOI: 10.1016/j.jacc.2023.03.420
Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease: One Step Closer to the Clinical Scenario
Keywords: aging; coronary artery disease; inflammation; prevention; risk factor.
Conflict of interest statement
Funding Support and Author Disclosures Research work by Drs Fuster and Izzi is supported by grant PLEC2021-008194 (funded by the Spanish Ministerio de Ciencia e Innovación, MCIN/AEI/10.13039/501100011033, and by the European Union “NextGenerationEU”/PRTR) and by grant LCF/PR/HR22/00732 from “La Caixa“ Foundation. The Centro Nacional de Investigaciones Cardiovasculares is supported by the MICIN, the Instituto de Salud Carlos III, and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant number CEX2020-001041 S). Dr Fuster is supported by grant RYC-2016-20026 (funded by MICIN/AEI/10.13039/501100011033’ and ‘ESF Investing in your future’). Dr Izzi is supported by the program “Atracción de Talento” of the Comunidad de Madrid (GN:2022-T1/BMD-23767).
Comment on
-
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.J Am Coll Cardiol. 2023 May 23;81(20):1996-2009. doi: 10.1016/j.jacc.2023.03.401. J Am Coll Cardiol. 2023. PMID: 37197843 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources